New publication regarding tobacco cessasion
Publication in PloS ONE about tobacco cessation by Tanja Tomson et al., Prevention-Policy and Practice at the Department of Learning, Informatics, Management and Ethics (LIME) coincides with Tobacco free week.
Timely, given last week’s Tobacco free week Anne Leppänen, Peter Lindgren, Carl Johan Sundberg, Max Petzold and Tanja Tomson are publishing a cRCT ”Motivation 2 Quit (M2Q): A cluster randomized controlled trial evaluating the effectiveness of Tobacco Cessation on Prescription (TCP) in Swedish primary healthcare” in PloS ONE.
The study is conducted at health centres in socioeconomically disadvantaged areas in Stockholm. The intervention consisted of TCP compared to standard treatment. Results showed that there was a statistically significant effect of TCP compared to standard treatment for the outcomes 7-day abstinence at 6 months (OR adjusted 5.4, 95% CI 1.57 to 18.93) and 3-month continued abstinence at 6 (OR adjusted 6.4, 95% CI 1.30 to 31.27) and 12 months follow-up (OR adjusted 7.8, 95% CI 1.25 to 48.82).
TCP may be effective in achieving abstinence from tobacco use compared to standard treatment in the given setting. Further research is recommended to confirm findings.
Conclusions: “TCP may be effective in achieving abstinence from tobacco use compared to standard treatment in the given setting but due to several limitations, resulting in high attrition rates and a low statistical power in the study, more research is needed to evaluate this.”
About the research group PPP
- The research group PPP, Prevention-Policy and Practice aims to generate evidence for effective prevention and promotion in national and global health care.
- This includes studies on the effectiveness of innovative tobacco prevention interventions in Swedish primary care. Also the role of big data for health care policy is studied in a new consortium. We use mixed methods and robust evaluation designs.
- Currently a collaborative prevention project between Karolinska Institutet and Stockholm region, aiming to develop a strategy for implementing a new treatment called “Tobacco Cessation on Prescription” with a focus on preventing mental ill health, is carried out.